1. Lyubov E.B., Sarkisyan G.R. Depressivnye rasstroistva: farmakoepidemiologicheskie i kliniko-ekonomicheskie aspekty. Sotsial'naya i klinicheskaya psikhiatriya 2006; 16: 2: 93—102.
2. Kessler R.C. The costs of depression. Psychiatr Clin North Am 2012; 35: 1—14.
3. Olesen J., Gustavsson A., Svensson M., Wittchen H.U. et al. The economic cost of brain disorders in Europe. Eur J Neurol 2012; 19: 155—162.
4. Gurovich I.Ya., Lyubov E.B. Farmakoepidemiologiya i farmakoekonomika v psikhiatrii. M: Medpraktika-M 2003; 264.
5. Kaplan C., Zhang Y. Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population. J Ment Health Policy Econ 2012; 15: 171—178.